About Gmbrc
Gmbrc is a Healthcare company based in India. GMBRC focuses on practical research and innovation for technology solutions. It operates on a B2B model. Gmbrc offers products and services including R&D Launchpad. Its focus areas include Technology, R&D and Innovation, Experimental Platforms and Scalable Advancements. Its legal entity in India is Gmbrc Biolabs Private Limited (U73100KL2019PTC059047).
Company details
GMBRC serves as a dedicated launchpad for startup RD and experimental platforms, facilitating practical research and innovation. It transforms ideas into scalable, technology-driven solutions that address industry needs and pressing challenges. The organization supports various projects through a team including experts like Dr. Geetha Viswanathan. While the exact location is not specified, it emphasizes creating meaningful innovations for real-world impact.
- Headquarters India
- SectorsHealthcare
- Email••••••••
- Website gmbrc.com
- Legal Name Gmbrc Biolabs Private Limited
- Date of Incorporation 30 Jul, 2019
- Jurisdiction Oyoor, Kollam, Kerala, India
- Annual Revenue₹7,600
FY 2023 · +1417% YoY
- Net Loss-₹14,953
FY 2023 · -197% margin
- EBITDA-₹14,640
FY 2023 · -193% margin
Associated legal entities of Gmbrc
Gmbrc operates through Gmbrc Biolabs Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2023) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Gmbrc Biolabs Private Limited CIN U73100KL2019PTC059047 | Active | 30 Jul 2019 | Kollam, Kerala | ₹0.0 Cr | – | 3 | View details |
Products & Services of Gmbrc
Gmbrc offers a comprehensive portfolio of products and services, including R&D Launchpad.
Platform for practical research and technology innovations
Board of directors of Gmbrc Biolabs Private Limited (Gmbrc)
Gmbrc Biolabs Private Limited is the primary company behind Gmbrc. The board of Gmbrc Biolabs Private Limited currently have 3 directors; the longest-serving is Rony K Roy, appointed in 2019.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Rony K Roy DIN 08524626 | Director | 30 Jul 2019 | 7 yrs 2 mo | Gmbrc Biolabs Private Limited |
| Thettikuzhiyil Kurikese Roy DIN 08524627 | Director | 30 Jul 2019 | 7 yrs 2 mo | Gmbrc Biolabs Private Limited |
| Angel Somer DIN 08954490 | Director | 11 Nov 2020 | 5 yrs 11 mo | Gmbrc Biolabs Private Limited |
Financials of Gmbrc
Figures of Gmbrc Biolabs Private Limited, the primary company behind Gmbrc, for FY 2023. Revenue was ₹7,600 (+1417% year on year). Net loss was -₹14,953 (-197% margin). EBITDA was -₹14,640 (-193% margin).
- ₹7,600Revenue · FY 2023 · +1417% YoY
- -₹14,953Net loss · -197% margin
- -₹14,640EBITDA · -193% margin
- ₹1 LakhPaid-up capital
Balance sheet, profit and loss, cash flow and ratios of Gmbrc Biolabs Private Limited are on its company page.
Detailed financial statements for Gmbrc
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
10 companies that operate in the same segment as Gmbrc (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | 1,111 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.34 B | USD 301.49 M | 1,372 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Gmbrc
Gmbrc is headquartered in India.
The primary company behind Gmbrc, Gmbrc Biolabs Private Limited, reported revenue of ₹7,600 for FY 2023, up 1417% year on year.
GMBRC serves as a dedicated launchpad for startup RD and experimental platforms, facilitating practical research and innovation. It transforms ideas into scalable, technology-driven solutions that address industry needs and pressing challenges. The organization supports various projects through a team including experts like Dr. Geetha Viswanathan. While the exact location is not specified, it emphasizes creating meaningful innovations for real-world impact.
Gmbrc offers R&D Launchpad.
Gmbrc operates through Gmbrc Biolabs Private Limited.
The legal entities of Gmbrc currently have 3 directors, including Angel Somer, Rony K Roy, Thettikuzhiyil Kurikese Roy.